Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Lee Enterprises | LEE | 1. avr 2025 | 10.39 | +0.10 |
Legacy Housing | LEGH | 1. avr 2025 | 25.16 | -0.24 |
LegalZoom.com | LZ | 1. avr 2025 | 8.72 | +1.28 |
Legato Merger III | LEGT | 1. avr 2025 | 10.43 | -0.57 |
Legend Biotech ADR | LEGN | 1. avr 2025 | 31.52 | -7.10 |
Legg Mason Low Volatility High Dividend ETF | LVHD | 1. avr 2025 | 40.85 | -0.29 |
Leggett & Platt | LEG | 1. avr 2025 | 7.86 | -0.63 |
Leidos | LDOS | 1. avr 2025 | 134.96 | +0.01 |
Leishen Energy Holding Co | LSE | 1. avr 2025 | 5.95 | +32.81 |
LeMaitre Vascular | LMAT | 1. avr 2025 | 85.16 | +1.50 |
Lemonade | LMND | 1. avr 2025 | 31.60 | +0.54 |
LendingClub | LC | 1. avr 2025 | 10.51 | +1.84 |
LendingTree | TREE | 1. avr 2025 | 52.76 | +4.95 |
Lendway | LDWY | 1. avr 2025 | 3.75 | 0.00 |
Lennar A | LEN | 1. avr 2025 | 114.51 | -0.24 |
Lennar B | LEN-B | 1. avr 2025 | 108.37 | -0.64 |
Lennox International | LII | 1. avr 2025 | 564.83 | +0.71 |
LENSAR | LNSR | 1. avr 2025 | 14.06 | -0.42 |
LENZ Therapeutics | LENZ | 1. avr 2025 | 26.01 | +1.17 |
Leonardo DRS | DRS | 1. avr 2025 | 32.87 | -0.03 |
Lesaka Technologies | LSAK | 1. avr 2025 | 5.00 | +4.82 |
Leslies | LESL | 1. avr 2025 | 0.75 | +2.38 |
Levi Strauss & Co A | LEVI | 1. avr 2025 | 16.38 | +5.07 |
Lexaria Bioscience | LEXX | 1. avr 2025 | 1.64 | -4.09 |
Lexeo Therapeutics | LXEO | 1. avr 2025 | 3.13 | -9.80 |
Lexicon Pharmaceuticals | LXRX | 1. avr 2025 | 0.46 | +0.72 |
LexinFintech ADR | LX | 1. avr 2025 | 10.24 | +1.49 |
LG Display ADR | LPL | 1. avr 2025 | 3.08 | -0.96 |
LGI Homes | LGIH | 1. avr 2025 | 66.02 | -0.68 |
LGL Group | LGL | 1. avr 2025 | 6.32 | -3.20 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.